Pharmaceutical firms conducting clinical trials of drugs in India will no longer be able to escape responsibility in case of injury or death of participants. According to new draft rules for clinical trials and new drugs, if the sponsor fails…
Indian pharma cos get record 300 USFDA generic drug nods in 2017
Domestic pharmacompanies received more than 300 approvals in 2017 to launch generic drugs in the US, which is an all-time high. The clearances came despite regulatory pressure from the US Food and Drug Administration (FDA), and unprecedented warning letters issued…
Indian pharma majors are rushing to ‘Make in America’
US President Donald Trump’s ‘Make in America’ pledge may have spooked many, but Indian pharmaceutical companies are optimistic. Several Indian drugmakers that have large operations in the US are now pushing to acquire assets there by either investing in greenfield…
Google invests in UK vaccine pioneer Vaccitech
Google has invested £20 million ($27.1m) in a biotech firm spun out of Oxford University working on novel treatments which include a universal flu vaccine and a therapeutic cancer vaccine. The tech giant’s GV division (formerly known as Google Ventures)…
